查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1670264

2025 年全球左心室輔助裝置市場報告

Left Ventricular Assist Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年左心室輔助裝置市場規模將強勁成長。到 2029 年，這一數字將成長至 25.2 億美元，複合年成長率為 9.6%。預測期內的成長將歸因於適應症的擴大、心臟衰竭病例數量的增加、患者預後的改善、市場核准和法規的變化以及對目的治療的關注。預測期內的主要趨勢包括植入技術的進步、雙泵系統的發展、作為目的治療的日益廣泛使用、注重降低感染風險、與心臟衰竭管理計劃的結合以及抗凝血管理的改善。

心血管疾病發生率的不斷上升預計將在未來幾年推動左心室輔助裝置市場的成長。心血管疾病包括多種影響心臟和血管的疾病，例如心臟疾病和先天性心臟疾病。當心臟衰竭進展時，左心室輔助裝置支撐心臟的左心室，負責將血液泵送到身體組織。例如，根據英國政府機構健康改善與差異辦公室 2024 年 3 月發布的資料，2023 年英格蘭有超過 1,862,500 人（3%）被診斷出患有心臟疾病(CHD)。此外，2022 年 12 月，紐約州政府的資料顯示，心臟病每年在美國導致約 697,000 人死亡，相當於每五人中就有一人死於心臟病。每年，大約有 805,000 名美國人會經歷心臟病發作：其中 605,000 人是首次心臟病發作，而 20 萬人是先前心臟病發作的結果。因此，心血管疾病盛行率的上升正在推動左心室輔助裝置市場的成長。

預計未來幾年醫療保健支出的增加將推動左心室輔助裝置市場的成長。醫療保健支出包括與提供基於健康的衛生服務、計劃生育活動、營養計劃、緊急援助等相關的所有費用。醫療保健支出的增加正在推動各種健康相關產品的進步和發展，包括左心室輔助裝置。增加醫療保健支出可能會對左心室輔助裝置市場的成長產生正面影響。例如，英國國家統計機構國家統計局報告稱，2022年英國醫療保健支出達到約3,548.8億美元（2,830億英鎊），與2021年支出相比名義成長0.7%。因此，醫療保健支出的增加正在推動左心室輔助裝置市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 世界左心室輔助循環裝置PESTEL分析（政治、社會、科技、環境、法律因素、促進因素、抑制因素）
  • 最終用途產業分析
  • 全球左心室輔助裝置市場：成長率分析
  • 全球左心室輔助裝置市場表現：規模與成長，2019 年至 2024 年
  • 全球左心室輔助裝置市場預測：2024-2029 年及 2034 年規模與成長
  • 全球左心室輔助裝置總目標市場 (TAM)

第6章 市場細分

  • 全球左心室輔助裝置市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 經皮左心室輔助循環裝置
  • 植入式左心室輔助裝置
  • 全球左心室輔助裝置市場流量（按類型、實際和預測），2019-2024 年、2024-2029 年、2034 年
  • 脈動
  • 非脈動
  • 全球左心室輔助裝置市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 復健橋樑 (BTR) 治療
  • 移植前橋接 (BTT) 治療
  • 目的地治療
  • 候選人資格橋樑 (BTC) 治療
  • 全球左心室輔助裝置市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
  • 心臟中心
  • 醫院
  • 全球左心室輔助裝置市場經皮左心室輔助裝置細分市場按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 臨時經皮裝置
  • 永久性經皮裝置
  • 全球左心室輔助裝置市場，按植入式左心室輔助裝置類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 連續流裝置
  • 脈動流裝置

第7章 區域和國家分析

  • 全球左心室輔助裝置市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球左心室輔助裝置市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

  • 左心室輔助裝置市場：競爭格局
  • 左心室輔助裝置市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
    • MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • LivaNova Plc
  • Thoratec Corporation
  • Abiomed Inc
  • Transonic Systems
  • Berlin Heart GmbH
  • BioVentrix
  • Cleveland Heart Inc.
  • Jarvik Heart Inc.
  • CorWave SA
  • SynCardia Systems LLC
  • NuPulseCV Inc.
  • Fineheart
  • Procyrion Inc
  • Carmat SA
  • BiVACOR Inc

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年左心室輔助裝置市場：提供新機會的國家
  • 2029 年左心室輔助裝置市場：提供新機會的細分市場
  • 2029 年左心室輔助裝置市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 36 章 附錄

簡介目錄
Product Code: r25064

A left ventricular assist device (LVAD) serves as a mechanical pump implanted in heart failure patients, assisting the heart's lower left chamber (left ventricle) in pumping blood to the aorta and throughout the body.

The primary types of left ventricular assist devices include transcutaneous left ventricular assist devices and implantable left ventricular assist devices. A transcutaneous left ventricular assist device is characterized by having both an external power supply and an internal pump located inside the body. Tubes connect the pump to the heart through small openings in the abdomen. This type of LVAD is often employed for short-term support during or following surgery. Left ventricular assist devices can have either pulsatile or non-pulsatile flows, and they are used in various therapeutic approaches such as bridge-to-recovery (BTR) therapy, bridge-to-transplant (BTT) therapy, destination therapy, and bridge-to-candidacy (BTC) therapy. Cardiology centers and hospitals typically utilize these devices for patient care.

The left ventricular assist devices market research report is one of a series of new reports from The Business Research Company that provides left ventricular assist devices market statistics, including the left ventricular assist devices industry's global market size, regional shares, competitors with a left ventricular assist devices market share, detailed left ventricular assist devices market segments, market trends, and opportunities, and any further data you may need to thrive in the left ventricular assist devices industry. This left ventricular assist devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.6 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to post-market surveillance and data, reduction in device size and noise, awareness and education programs, increased physician experience, and adoption in bridge therapy

The left ventricular assist devices market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expanded indications, a rise in heart failure cases, enhanced patient outcomes, market approval and regulatory changes, focus on destination therapy. Major trends in the forecast period include advancements in implantation techniques, development of dual-pump systems, growing use as a destination therapy, focus on minimizing infection risks, integration with heart failure management programs, and improved anticoagulation management.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the left ventricular assist device market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease and congenital heart disease, among others. In cases of advanced heart failure, a left ventricular assist device supports the heart's left ventricle, which is responsible for pumping blood to the body's tissues. For example, in March 2024, data released by the Office for Health Improvement and Disparities, a UK government agency, indicated that there were over 1,862,500 individuals (3%) diagnosed with coronary heart disease (CHD) in England in 2023. Additionally, in December 2022, data from the New York government revealed that heart disease is responsible for approximately 697,000 deaths annually in the United States, equating to 1 in every 5 fatalities. Each year, around 805,000 Americans experience a heart attack, with 605,000 being their first and 200,000 resulting from previous heart attacks. Therefore, the rising prevalence of cardiovascular diseases is fueling the growth of the left ventricular assist device market.

The increase in healthcare expenditures is expected to drive the growth of the left ventricular assist device market in the future. Healthcare expenditures encompass all costs related to providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. Higher healthcare spending can facilitate the advancement and development of various health-related products, including left ventricular assist devices. As healthcare expenditures rise, they will positively impact the growth of the left ventricular assist device market. For example, in 2022, the Office for National Statistics, a UK national statistics organization, reported that healthcare expenditure in the UK reached approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% compared to spending in 2021. Thus, the rise in healthcare expenditures is propelling the growth of the left ventricular assist device market.

Leading companies in the left ventricular assist devices market are focusing on developing technologies like power management units (PMUs) to improve the efficiency, reliability, and longevity of these devices. A power management unit (PMU) is an integrated circuit responsible for regulating and managing the power supply and distribution to various components within electronic devices. For example, in June 2022, Renesas Electronics, a semiconductor manufacturer based in Japan, introduced the SmartBond DA1470x. This family of products marks a significant advancement in Bluetooth Low Energy (BLE) technology, offering developers a versatile platform for creating innovative IoT products while optimizing costs and enhancing performance. The high level of integration in the SmartBond DA1470x simplifies design, boosts reliability, and shortens time-to-market across various applications.

Major companies in the left ventricular assist device industry are significantly investing in research, development, and early feasibility trials for their Total Artificial Heart (TAH). This substantial investment aligns with long-term goals, as demonstrated by BiVACOR, a US-based medical technology company that secured $18 million in funding for TAH development in March 2023. Led by Cormorant Asset Management and OneVentures, these funds will support research, early feasibility trials, and key executive hires. The BiVACOR TAH, designed for severe biventricular heart failure, incorporates advancements from Left Ventricular Assist Device (LVAD) technology, signaling a shift toward durable rotary blood pumps.

In December 2022, Johnson & Johnson, a prominent US-based pharmaceutical and medical technology company, completed the acquisition of Abiomed Inc for $16.6 billion. This strategic acquisition aimed to expand Johnson & Johnson's presence in the high-growth cardiovascular markets. Abiomed Inc., a US-based medical device technology company, specializes in providing circulatory and oxygenation support devices, including ventricular assist technology that pumps blood from the left ventricle (LV).

Major companies operating in the left ventricular assist devices market include Abbott Laboratories, Medtronic plc., Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., LivaNova Plc, Thoratec Corporation, Abiomed Inc, Transonic Systems, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., AdjuCor GmbH, Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc., Sun Medical Technology Research Corp

North America was the largest region in the left ventricular assist devices market in 2024. The regions covered in the left ventricular assist devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the left ventricular assist devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The left ventricular assist devices market consists of sales of rechargeable left ventricular assist devices, non-rechargeable left ventricular assist devices, heart pumps, and controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Left Ventricular Assist Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on left ventricular assist devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for left ventricular assist devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The left ventricular assist devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Transcutaneous Left Ventricular Assist Devices; Implantable Left Ventricular Assist Devices
  • 2) By Type Of Flow: Pulsatile; Non-Pulsatile
  • 3) By Application: Bridge-To-Recovery (BTR) Therapy; Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Candidacy (BTC) Therapy
  • 4) By End-User: Cardiology Centers; Hospitals
  • Subsegments:
  • 1) By Transcutaneous Left Ventricular Assist Devices: Temporary Transcutaneous Devices; Permanent Transcutaneous Devices
  • 2) By Implantable Left Ventricular Assist Devices: Continuous Flow Devices; Pulsatile Flow Devices
  • Companies Mentioned: Abbott Laboratories; Medtronic plc.; Terumo Corporation; St. Jude Medical; MAQUET GmbH & Co.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Left Ventricular Assist Devices Market Characteristics

3. Left Ventricular Assist Devices Market Trends And Strategies

4. Left Ventricular Assist Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Left Ventricular Assist Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Left Ventricular Assist Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Left Ventricular Assist Devices Market Growth Rate Analysis
  • 5.4. Global Left Ventricular Assist Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Left Ventricular Assist Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Left Ventricular Assist Devices Total Addressable Market (TAM)

6. Left Ventricular Assist Devices Market Segmentation

  • 6.1. Global Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcutaneous Left Ventricular Assist Devices
  • Implantable Left Ventricular Assist Devices
  • 6.2. Global Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pulsatile
  • Non-Pulsatile
  • 6.3. Global Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bridge-To-Recovery (BTR) Therapy
  • Bridge-To-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge-To-Candidacy (BTC) Therapy
  • 6.4. Global Left Ventricular Assist Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiology Centers
  • Hospitals
  • 6.5. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Transcutaneous Left Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Temporary Transcutaneous Devices
  • Permanent Transcutaneous Devices
  • 6.6. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Implantable Left Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Flow Devices
  • Pulsatile Flow Devices

7. Left Ventricular Assist Devices Market Regional And Country Analysis

  • 7.1. Global Left Ventricular Assist Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Left Ventricular Assist Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Left Ventricular Assist Devices Market

  • 8.1. Asia-Pacific Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Left Ventricular Assist Devices Market

  • 9.1. China Left Ventricular Assist Devices Market Overview
  • 9.2. China Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Left Ventricular Assist Devices Market

  • 10.1. India Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Left Ventricular Assist Devices Market

  • 11.1. Japan Left Ventricular Assist Devices Market Overview
  • 11.2. Japan Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Left Ventricular Assist Devices Market

  • 12.1. Australia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Left Ventricular Assist Devices Market

  • 13.1. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Left Ventricular Assist Devices Market

  • 14.1. South Korea Left Ventricular Assist Devices Market Overview
  • 14.2. South Korea Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Left Ventricular Assist Devices Market

  • 15.1. Western Europe Left Ventricular Assist Devices Market Overview
  • 15.2. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Left Ventricular Assist Devices Market

  • 16.1. UK Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Left Ventricular Assist Devices Market

  • 17.1. Germany Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Left Ventricular Assist Devices Market

  • 18.1. France Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Left Ventricular Assist Devices Market

  • 19.1. Italy Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Left Ventricular Assist Devices Market

  • 20.1. Spain Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Left Ventricular Assist Devices Market

  • 21.1. Eastern Europe Left Ventricular Assist Devices Market Overview
  • 21.2. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Left Ventricular Assist Devices Market

  • 22.1. Russia Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Left Ventricular Assist Devices Market

  • 23.1. North America Left Ventricular Assist Devices Market Overview
  • 23.2. North America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Left Ventricular Assist Devices Market

  • 24.1. USA Left Ventricular Assist Devices Market Overview
  • 24.2. USA Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Left Ventricular Assist Devices Market

  • 25.1. Canada Left Ventricular Assist Devices Market Overview
  • 25.2. Canada Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Left Ventricular Assist Devices Market

  • 26.1. South America Left Ventricular Assist Devices Market Overview
  • 26.2. South America Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Left Ventricular Assist Devices Market

  • 27.1. Brazil Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Left Ventricular Assist Devices Market

  • 28.1. Middle East Left Ventricular Assist Devices Market Overview
  • 28.2. Middle East Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Left Ventricular Assist Devices Market

  • 29.1. Africa Left Ventricular Assist Devices Market Overview
  • 29.2. Africa Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Left Ventricular Assist Devices Market Competitive Landscape And Company Profiles

  • 30.1. Left Ventricular Assist Devices Market Competitive Landscape
  • 30.2. Left Ventricular Assist Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

31. Left Ventricular Assist Devices Market Other Major And Innovative Companies

  • 31.1. LivaNova Plc
  • 31.2. Thoratec Corporation
  • 31.3. Abiomed Inc
  • 31.4. Transonic Systems
  • 31.5. Berlin Heart GmbH
  • 31.6. BioVentrix
  • 31.7. Cleveland Heart Inc.
  • 31.8. Jarvik Heart Inc.
  • 31.9. CorWave SA
  • 31.10. SynCardia Systems LLC
  • 31.11. NuPulseCV Inc.
  • 31.12. Fineheart
  • 31.13. Procyrion Inc
  • 31.14. Carmat SA
  • 31.15. BiVACOR Inc

32. Global Left Ventricular Assist Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Left Ventricular Assist Devices Market

34. Recent Developments In The Left Ventricular Assist Devices Market

35. Left Ventricular Assist Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Left Ventricular Assist Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Left Ventricular Assist Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Left Ventricular Assist Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer